Skip to content

Clinical trials

Thrombocythemia, Essential trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Country / region: France Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20053
20061
20102
20111
20133
20145
20151
20161
20173
20192
20201
20211
20221
20233
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting7
Active, not recruiting5
Terminated5
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
Shire4
Incyte Corporation3
University Hospital, Angers3
University Hospital, Brest3
AOP Orphan Pharmaceuticals AG2
CTI BioPharma2
Merck Sharp & Dohme LLC2
Sierra Oncology LLC - a GSK company2
University Hospital, Bordeaux2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential37
Polycythemia Vera20
Primary Myelofibrosis19
Myeloproliferative Disorders18
Hematologic Diseases6
Bone Marrow Diseases5
Leukemia, Myeloid, Acute5
Leukemia, Myelomonocytic, Chronic5
Neoplasms5
Blast Crisis4

Trials

Showing 76 to 37 of 37. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.